In the FAK western blot, we used an antibody that detects FAK phosphorylation on Tyr 397, which is required for FAK activation and increases in association with loss of cell-to-substrate adhesion, increased motility and invasive capacity, as well as correlating with tumor staging in several cancer types [27]. The gene discussed is PTK2; the disease is neoplasm.